Tab, Neuroreport 7 (8) 1382-4 May 31, 1996. |
Karmeli et al, GUT, 38(6) 826-31 Jun. 1996. |
Monte et al, Free Radical Biol. Med., 21(4) 463-470 1996. |
C.J. Bulpitt et al., "Vitamin C and blood pressure," J. Hypertens, 8(12):1071-5 (1990). |
D. Giugliano et al., "Diabetes Mellitus, hypertension, and cardiovascular disease: which role for oxidative stress?." Metabolism 44(3):363-8 (1995). |
S. Grunfeld et al., "Role of Superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats," Hypertension 26(6 Pt 1):854-7 (1995). |
R.J. Gryglewski et al., "Superoxide anion is involved in the breakdown of endothelium--derived vascular relaxing factor," Nature 320(6061): 454-6 (1986). |
D.G. Harrison et al., "Physiologic consequences of increased vascular oxidant stresses in hypercholesterolemia and atherosclerosis: implications for impaired vasomotion," Am. J. Cardiol 75(6): 75B-81B (1995). |
V.V. Khramtsov et al., "In vitro and in vivo studies of the derivatives of 1,2-diazetine and nitronylnitroxide as donors and acceptors of nitric oxide," Biokhimiya, 61(10): 1731-1742 (1996). |
K.V. Kumar et al., "Are free radicals involved in the pathobiology of human essential hypertension?," Ree Radic Res Commun. 19(1): 59-66 (1993). |
J. M. McCord, "Oxygen-derived free radicals in postischermic tissue injury," N. Engl. J. Med. 312(3): 159-63 (1985). |
Y. Miyamoto et al., "Potentiation of nitric oxide-mediated vasorelaxation by xanthine oxidase inhibitors," Proc. Soc. Exp. Biol. Med. 312(4): 366-373 (1996). |
K. Nakazono et al., "Does superoxide underlie the pathogenesis of hypertension?" Proc. Natl. Acad. Sci. USA 88: 10045-10048 (1991). |
G.M. Rubanyi et al., "Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor," Am. J. Physiol. 250: H822-H827 (1986). |
C.G. Schnackenberg et al., "Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic," Hypertension, 32(1): 59-64 (1998). |
C.G. Schnackenberg et al., "Long-term tempol administration attenuates the hypertension and production of 8-iso prostaglandin F2a in SHR." Hypertension 32(3): 622 (1998). |
H. Suzuki et al., "In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats, Hydroethidine microfluorography," Hypertension 25(5): 1083-1089 (1995). |
M.R. Tschudi et al., "Direct in situ measurement of nitric oxide in mesenteric arteries. Increased decomposition by superoxide in hypertension." Hypertension 27(1): 32-35 (1996). |
W.Y Tse et al., "Antioxidant status in controlled and uncontrolled hypertension and its relationship to endothelial damage." J. Hum. Hypertens. 89:843-849 (1994). |
M. Yoshioka et al., "Effects of ascorbic acid on blood pressure and ascorbic acid metabolism in spontaneously hypertensive rates (SH Rats)." Internat. J. Vit. Nutr. Res. 55:301-307 (1985). |